BRPI0406879A - Dispositivo de liberação sustentada e método para a liberação ocular de agentes adrenérgicos - Google Patents
Dispositivo de liberação sustentada e método para a liberação ocular de agentes adrenérgicosInfo
- Publication number
- BRPI0406879A BRPI0406879A BR0406879-3A BRPI0406879A BRPI0406879A BR PI0406879 A BRPI0406879 A BR PI0406879A BR PI0406879 A BRPI0406879 A BR PI0406879A BR PI0406879 A BRPI0406879 A BR PI0406879A
- Authority
- BR
- Brazil
- Prior art keywords
- adrenergic agents
- sustained release
- release
- ocular
- release device
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/432—Inhibitors, antagonists
- A61L2300/434—Inhibitors, antagonists of enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
- A61L2300/608—Coatings having two or more layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Nanotechnology (AREA)
- Emergency Medicine (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44249903P | 2003-01-24 | 2003-01-24 | |
US48267703P | 2003-06-26 | 2003-06-26 | |
US48331603P | 2003-06-26 | 2003-06-26 | |
US50197403P | 2003-09-11 | 2003-09-11 | |
PCT/US2004/001718 WO2004066979A2 (en) | 2003-01-24 | 2004-01-23 | Sustained release device and method for ocular delivery of adrenergic agents |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI0406879A true BRPI0406879A (pt) | 2006-01-03 |
BRPI0406879B1 BRPI0406879B1 (pt) | 2015-12-22 |
Family
ID=32831098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0406879A BRPI0406879B1 (pt) | 2003-01-24 | 2004-01-23 | dispositivo de liberação de droga de liberação sustentada |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1592408B1 (pt) |
JP (1) | JP2006516618A (pt) |
KR (1) | KR20050118161A (pt) |
AR (1) | AR042917A1 (pt) |
AT (1) | ATE440595T1 (pt) |
AU (1) | AU2004207506B2 (pt) |
BR (1) | BRPI0406879B1 (pt) |
CA (1) | CA2513751C (pt) |
DE (1) | DE602004022776D1 (pt) |
DK (1) | DK1592408T3 (pt) |
ES (1) | ES2332720T3 (pt) |
MX (1) | MXPA05007719A (pt) |
SI (1) | SI1592408T1 (pt) |
TW (1) | TWI356714B (pt) |
WO (1) | WO2004066979A2 (pt) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE451915T1 (de) * | 2003-01-24 | 2010-01-15 | Psivida Inc | Vorrichtung zur verlängerten freisetzung und methode zur okularen verabreichung von carboanhydrase inhibitoren |
US20050244463A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Sustained release intraocular implants and methods for treating ocular vasculopathies |
US8425929B2 (en) * | 2004-04-30 | 2013-04-23 | Allergan, Inc. | Sustained release intraocular implants and methods for preventing retinal dysfunction |
CA2572592C (en) | 2004-07-02 | 2015-09-08 | Eliot Lazar | Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device |
JP5208916B2 (ja) * | 2006-03-31 | 2013-06-12 | キュー エル ティー インク. | 鼻涙系用の薬物送達方法、構造および組成物 |
CN101505696B (zh) * | 2006-06-21 | 2012-11-14 | 庄臣及庄臣视力保护公司 | 用于递送活性试剂的泪点塞 |
US9173773B2 (en) | 2006-06-21 | 2015-11-03 | Johnson & Johnson Vision Care, Inc. | Punctal plugs for the delivery of active agents |
FR2906712A1 (fr) * | 2006-10-09 | 2008-04-11 | France Chirurgie Instr | Bouchon meatique a pose simplifiee. |
JP2010514517A (ja) * | 2006-12-26 | 2010-05-06 | キューエルティー プラグ デリバリー,インク. | 視覚欠損の抑制のための薬物送達インプラント |
MX2010002616A (es) * | 2007-09-07 | 2010-08-04 | Qlt Plug Delivery Inc | Nucleos de farmaco para la liberacion sostenida de agentes terapeuticos. |
EP2865361B1 (en) * | 2007-09-07 | 2019-05-22 | Mati Therapeutics Inc. | Lacrimal implants and related methods |
US20090264477A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc., An Indiana Corporation | Beta adrenergic receptor agonists for treatment of pain and/or inflammation |
CA2722971C (en) * | 2008-05-09 | 2019-05-07 | Qlt Plug Delivery, Inc. | Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
US10064819B2 (en) | 2008-05-12 | 2018-09-04 | University Of Utah Research Foundation | Intraocular drug delivery device and associated methods |
CN102105118A (zh) * | 2008-06-24 | 2011-06-22 | Qlt栓塞输送公司 | 青光眼的联合治疗 |
US9095506B2 (en) | 2008-11-17 | 2015-08-04 | Allergan, Inc. | Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof |
WO2010071844A1 (en) * | 2008-12-19 | 2010-06-24 | Qlt Plug Delivery, Inc | Substance delivering punctum implants and methods |
EP2379027A1 (en) * | 2009-01-02 | 2011-10-26 | Alcon Research, Ltd. | In-situ refillable ophthalmic implant |
US20120322882A1 (en) | 2009-11-09 | 2012-12-20 | Allergan, Inc. | Compositions And Methods For Stimulating Hair Growth |
KR20130086131A (ko) * | 2010-04-06 | 2013-07-31 | 알러간, 인코포레이티드 | 전방내 약물 송달을 위한 서-방출 저장소 임플란트 |
US8349005B2 (en) | 2011-01-03 | 2013-01-08 | Masatoshi Murata | Method for burying implant to choroid |
WO2013011511A1 (en) | 2011-07-18 | 2013-01-24 | Mor Research Applications Ltd. | A device for adjusting the intraocular pressure |
EP2956096A1 (en) | 2013-02-15 | 2015-12-23 | Allergan, Inc. | Sustained drug delivery implant |
RU2019134877A (ru) * | 2017-06-13 | 2021-07-13 | Айпойнт Фармасьютикалс, Инк. | Биоразрушаемое устройство для доставки лекарственного средства |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5378475A (en) * | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
US5902598A (en) * | 1997-08-28 | 1999-05-11 | Control Delivery Systems, Inc. | Sustained release drug delivery devices |
US6196993B1 (en) * | 1998-04-20 | 2001-03-06 | Eyelab Group, Llc | Ophthalmic insert and method for sustained release of medication to the eye |
US6375972B1 (en) * | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
-
2004
- 2004-01-23 CA CA2513751A patent/CA2513751C/en not_active Expired - Fee Related
- 2004-01-23 KR KR1020057013643A patent/KR20050118161A/ko not_active Application Discontinuation
- 2004-01-23 MX MXPA05007719A patent/MXPA05007719A/es active IP Right Grant
- 2004-01-23 AU AU2004207506A patent/AU2004207506B2/en not_active Ceased
- 2004-01-23 AT AT04704837T patent/ATE440595T1/de not_active IP Right Cessation
- 2004-01-23 DE DE602004022776T patent/DE602004022776D1/de not_active Expired - Lifetime
- 2004-01-23 WO PCT/US2004/001718 patent/WO2004066979A2/en active Application Filing
- 2004-01-23 AR ARP040100201A patent/AR042917A1/es unknown
- 2004-01-23 SI SI200431291T patent/SI1592408T1/sl unknown
- 2004-01-23 DK DK04704837T patent/DK1592408T3/da active
- 2004-01-23 JP JP2006502933A patent/JP2006516618A/ja active Pending
- 2004-01-23 EP EP04704837A patent/EP1592408B1/en not_active Expired - Lifetime
- 2004-01-23 ES ES04704837T patent/ES2332720T3/es not_active Expired - Lifetime
- 2004-01-23 BR BRPI0406879A patent/BRPI0406879B1/pt not_active IP Right Cessation
- 2004-01-27 TW TW093101751A patent/TWI356714B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2006516618A (ja) | 2006-07-06 |
AR042917A1 (es) | 2005-07-06 |
WO2004066979A2 (en) | 2004-08-12 |
KR20050118161A (ko) | 2005-12-15 |
TWI356714B (en) | 2012-01-21 |
SI1592408T1 (sl) | 2010-01-29 |
EP1592408A2 (en) | 2005-11-09 |
CA2513751A1 (en) | 2004-08-12 |
ES2332720T3 (es) | 2010-02-11 |
CA2513751C (en) | 2012-01-10 |
EP1592408B1 (en) | 2009-08-26 |
AU2004207506A1 (en) | 2004-08-12 |
TW200500099A (en) | 2005-01-01 |
ATE440595T1 (de) | 2009-09-15 |
MXPA05007719A (es) | 2005-09-30 |
DK1592408T3 (da) | 2010-01-04 |
BRPI0406879B1 (pt) | 2015-12-22 |
AU2004207506B2 (en) | 2009-10-08 |
DE602004022776D1 (de) | 2009-10-08 |
WO2004066979A3 (en) | 2004-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0406879A (pt) | Dispositivo de liberação sustentada e método para a liberação ocular de agentes adrenérgicos | |
BRPI0406880A (pt) | Dispositivo de liberação sustentada e método para a liberação ocular de inibidores de anidrase carbÈnicos | |
BR0317774A (pt) | Uso de rimexolona no tratamento de olho seco | |
WO2003047513A3 (en) | Method for treating ocular hypertension | |
WO2004004757A8 (en) | Treatment for eye disorder | |
TW200633709A (en) | Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions | |
ECSP034815A (es) | "composiciones de timolol y de lipido hipotensivas y los metodos para utilizarlas" | |
BRPI0408690A (pt) | composto, método para tratamento de uma doença, composição farmacêutica, e, uso de um composto | |
BR0316203A (pt) | Uso de um agente antialérgico e um esteróide para tratar rinite alérgica | |
WO2005002520A3 (en) | Ophthalmic compositions for treating ocular hypertension | |
HUP0001818A2 (hu) | A szem első kamrájában alkalmazható szabályzott felszabadulású gyógyszerhatóanyagok | |
BR0212877A (pt) | Emulsão de água-em-óleo, composição, e, métodos para umectar pele de mamìfero, para desinfetar tecido de mamìfero e para suprir um agente farmacêutico a um mamìfero | |
MX9405006A (es) | Solucion oftalmica para lagrimas artificiales. | |
DE60235775D1 (de) | Intraluminale Vorrichtung mit einer therapeutisches-mittel enthaltenden Beschichtung | |
BR0210241A (pt) | Piranoindazóis e seu uso no tratamento de glaucoma | |
TR200400526T4 (tr) | Göz kurumasının tedavisi için lipoksin A4 ve analogları | |
BR0209327A (pt) | Composição para tratamento de constipação induzida por drogas | |
EA200300560A1 (ru) | Улучшенный способ лечения | |
AR020660A1 (es) | Composiciones antibioticas para el tratamiento de ojos, oidos y nariz | |
BR0210238A (pt) | Novos análogos de aril-amino-propano e seu uso para o tratamento de glaucoma | |
AR054435A1 (es) | Agente para profilaxis o terapia contra la depresion o desorden de ansiedad | |
UY28202A1 (es) | Utilización de esteroides en el tratamiento de personas que sufren trastonos oculares. | |
BR0017158A (pt) | Agonistas de 5ht2 para controlar a iop e tratar o glaucoma | |
DE60135972D1 (de) | Orhthalmologische zusammenstellungen zur behandlung von ocularer hypertension | |
BR0314419A (pt) | Compostos de 5-croman-5-il-etilamina substituìdos, seu uso e composição farmacêutica incluindo-o |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: A CLASSIFICACAO ANTERIOR ERA: A61K 9/22 Ipc: A61K 9/22 (2006.01), A61P 27/06 (2006.01) |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 22/12/2015, OBSERVADAS AS CONDICOES LEGAIS. |
|
B25D | Requested change of name of applicant approved | ||
B25D | Requested change of name of applicant approved | ||
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 15A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2498 DE 21-11-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |